Pharmaceuticals & Medical Products


The new world of patient engagement

– The CEO of Acorda Therapeutics, Ron Cohen, explains how the biotechnology company’s relationship with patients is changing and what that means.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights


Transforming pharma commercial models in the age of the digital citizen

– Digital citizens—astute consumers of information and social media—require pharma to meet their expectations at each... point on the decision journey. Leading companies are updating their commercial models in five ways.

Voices on transformation: How to sustain healthcare transformations

– Industry leaders explore the challenges of transforming pharmaceutical and medical-products organizations.

Pharma M&A: Agile shouldn’t mean ad hoc

– Under pressure to be active acquirers, some pharmaceutical and medical-products companies may be neglecting best practices. Here’s... where they can most improve.
Interview - McKinsey Quarterly

Organizing for breakthrough innovation

– Roche’s CEO talks about its R&D structure, tough decisions, and long-term mind-set.

How pharma can win in a digital world

– The digital revolution is well under way for pharma companies. We spoke with 20 leading executives to find out how they cope—and... what they do to stay ahead.

The role of big data in medicine

– Technology is revolutionizing our understanding and treatment of disease, says the founding director of the Icahn Institute for... Genomics and Multiscale Biology at New York’s Mount Sinai Health System.

Improving healthcare while curbing cost: Med-tech companies offer a solution

– Research tells us that the potential value of partnering with med-tech companies is great. Yet many hospital executives are still... not fully satisfied.

The road to digital success in pharma

– Pharmaceutical companies can play a central role in the digital revolution of healthcare. But capturing this opportunity requires... identifying the right initiatives.

Capturing returns in healthcare

– New research finds that the healthcare sector has been very good to private equity, especially payor and pharmaceutical services.... And specialist firms seem to have an edge over generalists.

Pharma’s next challenge

– Emerging markets are becoming ever more important for pharma. Yet to be successful, a rapid shift from a marketing and sales focus... to an access-driven commercial model must occur.

Africa: A continent of opportunity for pharma and patients

– Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving... that strength and how companies should react.

Connect with our Pharmaceuticals & Medical Products Practice